Biolife Solutions (BLFS) Shares Outstanding (Weighted Average) (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $48.5 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $48.5 million, up 2.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $48.5 million (up 2.81% YoY), and the FY2025 annual result was $47.8 million, up 3.66% from the prior year.
• Shares Outstanding (Weighted Average) improved to $48.5 million in Q1 2026 per BLFS's latest filing, from $47.8 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $48.5 million in Q1 2026 and troughed at $42.5 million in Q2 2022.
• A 5-year average of $45.2 million and a median of $45.7 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) gained 13.92% in 2022, then gained 2.16% in 2023.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $42.5 million in 2022, then gained by 2.91% to $43.7 million in 2023, then gained by 5.37% to $46.1 million in 2024, then advanced by 3.66% to $47.8 million in 2025, then increased by 1.48% to $48.5 million in 2026.
• Business Quant data shows BLFS's Shares Outstanding (Weighted Average) at $48.5 million in Q1 2026, $47.8 million in Q4 2025, and $47.6 million in Q3 2025.